Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Link opens in a new tab
Search content at UTMB Health Research Expert Profiles
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Yellow Fever Vaccine
J. Erin Staples
, Emily H. Davis
, Thomas P. Monath
, Alan D.T. Barrett
Pathology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
7
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Yellow Fever Vaccine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Next-generation Vaccines
100%
Yellow Fever Vaccine
100%
Immune Response
50%
Epidemiology
50%
Virus Transmission
50%
Immunogenicity
50%
Vaccination
50%
Yellow Fever
50%
Tropical South America
50%
Sub-Saharan Africa
50%
Clinical Disease
50%
Vaccine Delivery
50%
Virology
50%
Viremia
50%
Highly Effective
50%
Viral Hemorrhagic Fever
50%
Hepatic Injury
50%
Long-term Immunity
50%
Travellers
50%
Endemic Region
50%
Myocardial Injury
50%
Renal Injury
50%
Dose Sparing
50%
Systemic Disease
50%
Reactogenicity
50%
Inactivated Vaccine
50%
Alternative Delivery
50%
High Lethality
50%
Hemorrhage
50%
Delivery Route
50%
Disease Presentation
50%
Medicine and Dentistry
Yellow Fever Virus
100%
Yellow Fever Vaccine
100%
Cohort Effect
50%
Virus Transmission
50%
Immune Response
50%
Liver Injury
50%
Virus Vaccine
50%
Immunogenicity
50%
Viremia
50%
Heart Muscle Injury
50%
Kidney Injury
50%
Viral Hemorrhagic Fever
50%
Lethality
50%
Systemic Disorder
50%
Inactivated Vaccine
50%
Diseases
50%
Side Effect
50%
Pathogenesis
50%
Bleeding
50%
Reactogenicity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Yellow Fever Virus
100%
Yellow Fever Vaccine
100%
Diseases
100%
Immunogenicity
50%
Lethality
50%
Liver Injury
50%
Virus Hemorrhagic Fever
50%
Virus Vaccine
50%
Virus Transmission
50%
Viremia
50%
Heart Muscle Injury
50%
Kidney Injury
50%
Inactivated Vaccine
50%
Side Effect
50%
Pathogenesis
50%
Vaccination
50%
Epidemiology
50%
Immunology and Microbiology
Yellow Fever Virus
100%
Yellow Fever Vaccine
100%
Immune Response
50%
Virus Transmission
50%
Immunogenicity
50%
Virus Vaccine
50%
Hemorrhagic Fever
50%
Viremia
50%
Inactivated Vaccine
50%
Virology
50%
Cohort Effect
50%
Epidemiology
50%